Literature DB >> 1810202

Development of resistance to ciprofloxacin in nutrient-rich and nutrient-limited growth conditions in vitro by Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

M I Ferguson1, E M Scott, P S Collier.   

Abstract

Five serial exposures of mucoid Pseudomonas aeruginosa from patients with cystic fibrosis to subinhibitory concentrations of ciprofloxacin resulted in stepwise increases in the MIC, with a mean proportional increase of 10. MICs were significantly lower in an iron-limited chemically defined medium than in Iso-Sensitest broth. The mucoid phenotype was maintained in chemically defined medium. Acquired resistance was retained either partially or completely in 85% of the isolates following 10 transfers in drug-free media. In cases in which susceptibility was regained, an increase in the MIC was observed on one further exposure to ciprofloxacin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1810202      PMCID: PMC245449          DOI: 10.1128/AAC.35.12.2649

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Persistence of Pseudomonas aeruginosa during ciprofloxacin therapy of a cystic fibrosis patient: transient resistance to quinolones and protein F-deficiency.

Authors:  S Chamberland; F Malouin; H R Rabin; T Schollaardt; T R Parr; L E Bryan
Journal:  J Antimicrob Chemother       Date:  1990-06       Impact factor: 5.790

2.  Ciprofloxacin therapy in cystic fibrosis.

Authors:  J A Raeburn; J R Govan; W M McCrae; A P Greening; P S Collier; M E Hodson; M C Goodchild
Journal:  J Antimicrob Chemother       Date:  1987-09       Impact factor: 5.790

3.  Generation times of Proteus mirabilis and Escherichia coli in experimental infections.

Authors:  W W Eudy; S E Burrous
Journal:  Chemotherapy       Date:  1973       Impact factor: 2.544

4.  Influence of substrate limitation and growth phase on sensitivity to antimicrobial agents.

Authors:  M R Brown; P Williams
Journal:  J Antimicrob Chemother       Date:  1985-01       Impact factor: 5.790

5.  Bacterial adherence to epithelial cells in bacillary colonization of the respiratory tract.

Authors:  W G Johanson; J H Higuchi; T R Chaudhuri; D E Woods
Journal:  Am Rev Respir Dis       Date:  1980-01

6.  In-vitro studies with ciprofloxacin, a new 4-quinolone compound.

Authors:  D S Reeves; M J Bywater; H A Holt; L O White
Journal:  J Antimicrob Chemother       Date:  1984-04       Impact factor: 5.790

7.  Ciprofloxacin monotherapy for acute pulmonary exacerbations of cystic fibrosis.

Authors:  J Goldfarb; R C Stern; M D Reed; T S Yamashita; C M Myers; J L Blumer
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

8.  Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis.

Authors:  I Shalit; H R Stutman; M I Marks; S A Chartrand; B C Hilman
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

9.  In-vitro selection of bacteria resistant to the 4-quinolone agents.

Authors:  D I Limb; D J Dabbs; R C Spencer
Journal:  J Antimicrob Chemother       Date:  1987-01       Impact factor: 5.790

10.  Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar.

Authors:  J H Tenney; R W Maack; G R Chippendale
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

View more
  2 in total

1.  Complex ciprofloxacin resistome revealed by screening a Pseudomonas aeruginosa mutant library for altered susceptibility.

Authors:  Elena B M Breidenstein; Bhavjinder K Khaira; Irith Wiegand; Joerg Overhage; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2008-09-29       Impact factor: 5.191

Review 2.  Bacterial antibiotic resistance development and mutagenesis following exposure to subinhibitory concentrations of fluoroquinolones in vitro: a systematic review of the literature.

Authors:  Carly Ching; Ebiowei S F Orubu; Indorica Sutradhar; Veronika J Wirtz; Helen W Boucher; Muhammad H Zaman
Journal:  JAC Antimicrob Resist       Date:  2020-09-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.